EKR Therapeutics and PDL BioPharma (PDLI) Sign Asset Purchase Agreement for Cardiovascular Products
Tweet Send to a Friend
EKR Therapeutics, Inc. and PDL BioPharma, Inc. (Nasdaq: PDLI) announced that they have entered into an agreement under which EKR ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
